Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

Peter Schmid, Stephen (Steve) Chui, Leisha A. Emens

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)987-988
Number of pages2
JournalThe New England journal of medicine
Volume380
Issue number10
DOIs
StatePublished - Mar 7 2019
Externally publishedYes

Fingerprint

Triple Negative Breast Neoplasms
Paclitaxel
Albumins
Monoclonal Antibodies
130-nm albumin-bound paclitaxel
MPDL3280A

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply. / Schmid, Peter; Chui, Stephen (Steve); Emens, Leisha A.

In: The New England journal of medicine, Vol. 380, No. 10, 07.03.2019, p. 987-988.

Research output: Contribution to journalLetter

Schmid, Peter ; Chui, Stephen (Steve) ; Emens, Leisha A. / Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply. In: The New England journal of medicine. 2019 ; Vol. 380, No. 10. pp. 987-988.
@article{25cdd5813af540d2aedfe6c865d06ad2,
title = "Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply",
author = "Peter Schmid and Chui, {Stephen (Steve)} and Emens, {Leisha A.}",
year = "2019",
month = "3",
day = "7",
doi = "10.1056/NEJMc1900150",
language = "English (US)",
volume = "380",
pages = "987--988",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "10",

}

TY - JOUR

T1 - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

AU - Schmid, Peter

AU - Chui, Stephen (Steve)

AU - Emens, Leisha A.

PY - 2019/3/7

Y1 - 2019/3/7

UR - http://www.scopus.com/inward/record.url?scp=85062894083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062894083&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1900150

DO - 10.1056/NEJMc1900150

M3 - Letter

VL - 380

SP - 987

EP - 988

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -